![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=1553-4669&client=dukeuniv)
An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.
Publication
, Other
Parker, W; Berek, JS; Pritts, E; Olive, D; Kaunitz, AM; Chalas, E; Clarke-Pearson, D; Goff, B; Bristow, R; Taylor, HS; Farias-Eisner, R ...
Published in: J Minim Invasive Gynecol
2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Minim Invasive Gynecol
DOI
EISSN
1553-4669
Publication Date
2016
Volume
23
Issue
3
Start / End Page
303 / 308
Location
United States
Related Subject Headings
- Obstetrics & Reproductive Medicine
- 3215 Reproductive medicine
- 1114 Paediatrics and Reproductive Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Parker, W., Berek, J. S., Pritts, E., Olive, D., Kaunitz, A. M., Chalas, E., … DeLancey, J. (2016). An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. J Minim Invasive Gynecol. United States. https://doi.org/10.1016/j.jmig.2015.12.012
Parker, William, Jonathan S. Berek, Elizabeth Pritts, David Olive, Andrew M. Kaunitz, Eva Chalas, Daniel Clarke-Pearson, et al. “An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.” J Minim Invasive Gynecol, 2016. https://doi.org/10.1016/j.jmig.2015.12.012.
Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, et al. An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. Vol. 23, J Minim Invasive Gynecol. 2016. p. 303–8.
Parker, William, et al. “An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.” J Minim Invasive Gynecol, vol. 23, no. 3, 2016, pp. 303–08. Pubmed, doi:10.1016/j.jmig.2015.12.012.
Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, Clarke-Pearson D, Goff B, Bristow R, Taylor HS, Farias-Eisner R, Fader AN, Maxwell GL, Goodwin SC, Love S, Gibbons WE, Foshag LJ, Leppert PC, Norsigian J, Nager CW, Johnson T, Guzick DS, As-Sanie S, Paulson RJ, Farquhar C, Bradley L, Scheib SA, Bilchik AJ, Rice LW, Dionne C, Jacoby A, Ascher-Walsh C, Kilpatrick SJ, Adamson GD, Siedhoff M, Israel R, Paraiso MF, Frumovitz MM, Lurain JR, Al-Hendy A, Benrubi GI, Raman SS, Kho RM, Anderson TL, Reynolds RK, DeLancey J. An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. J Minim Invasive Gynecol. 2016. p. 303–308.
![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=1553-4669&client=dukeuniv)
Published In
J Minim Invasive Gynecol
DOI
EISSN
1553-4669
Publication Date
2016
Volume
23
Issue
3
Start / End Page
303 / 308
Location
United States
Related Subject Headings
- Obstetrics & Reproductive Medicine
- 3215 Reproductive medicine
- 1114 Paediatrics and Reproductive Medicine